Managing JPS: From Endoscopy to Emerging Therapies
At a Glance
The primary treatment for Juvenile Polyposis Syndrome (JPS) is regular endoscopic removal of polyps to prevent cancer. Severe cases may require surgeries like a colectomy or gastrectomy, while medications like sirolimus offer new ways to shrink polyps and delay surgery in infants and children.
The management of Juvenile Polyposis Syndrome (JPS) is a lifelong commitment focused on two main goals: controlling symptoms and preventing cancer. Because every person’s genetic profile and polyp growth pattern are different, treatment must be personalized. Your care team will use a combination of procedures, monitoring, and sometimes medications to keep the digestive tract healthy.
First-Line Treatment: Endoscopic Polypectomy
The “gold standard” for managing JPS is endoscopic polypectomy [1][2]. During a routine colonoscopy or upper endoscopy, a doctor uses a specialized tool to snip out and remove polyps as they are found.
- The Goal: To reduce the overall “polyp burden” (the number of polyps in the body) and remove any polyps that could potentially turn into cancer over time [1][3].
- Frequency: Depending on how fast polyps grow, these procedures may happen every 1 to 3 years, though some patients may need them more frequently if their polyp growth is aggressive [4].
Balancing the Risks of Procedures
While endoscopies prevent cancer, undergoing invasive procedures and anesthesia frequently is not without risk. Potential complications of repeated colonoscopies and endoscopies include bleeding at the site of polyp removal and, rarely, bowel perforation (a small tear in the intestinal wall).
Your care team constantly weighs these procedural risks against the very real threat of cancer [2]. This is why building a care team with highly skilled, polyposis-experienced gastroenterologists is so important—they have the expertise to remove large polyps safely and minimize complications.
Additionally, the bowel prep required before a colonoscopy—drinking a large volume of laxative fluid to clear the intestines—can be physically and emotionally taxing, especially for children and teens. Do not hesitate to ask your medical team for tips, split-dose strategies, or alternative prep options to make this necessary hurdle more manageable.
When is Surgery Necessary?
While the goal is always to keep the digestive tract intact, surgery may be necessary if the disease becomes too difficult to manage with endoscopy alone. Common reasons for surgery include:
- Unmanageable Polyp Burden: If there are so many polyps that a doctor cannot safely remove them all during an endoscopy [5].
- High-Grade Dysplasia or Cancer: If a biopsy shows dysplasia (precancerous cell changes) that are advanced or if actual cancer is detected [2][6].
- Severe Symptoms: If a patient suffers from life-threatening bleeding, severe anemia that won’t improve, or significant protein-losing enteropathy (where the body loses vital proteins through the gut) [7][8].
Surgical Options:
- Total Colectomy: Removal of the large intestine (colon).
- Total Gastrectomy: Removal of the stomach. This is more common in patients with the SMAD4 mutation, who are at a higher risk for aggressive stomach polyps [7][5].
Emerging Medical Therapy: Sirolimus
For some patients, especially those with the severe Juvenile Polyposis of Infancy (JPI), a medication called sirolimus (an mTOR inhibitor) is becoming a valuable tool [9][10].
- How it Works: Sirolimus targets a specific growth pathway in the body that is often overactive in JPS.
- Benefits: It has been shown to shrink polyps, reduce intestinal bleeding, and improve protein levels [9][11].
- Delaying Surgery: In many cases, sirolimus can help stabilize an infant or child, allowing them to grow and potentially delaying or even avoiding major surgery until they are older and stronger [9][10].
Tailoring the Approach
Your treatment plan will depend heavily on your genetic mutation. For example, if you have a SMAD4 mutation, your doctors will be much more vigilant about monitoring your stomach because of the higher risk of aggressive disease there [4][12]. Always discuss the pros and cons of “watchful waiting” via endoscopy versus more definitive surgical options with your specialist.
Common questions in this guide
How are polyps treated in Juvenile Polyposis Syndrome?
When is surgery necessary for JPS?
What is sirolimus and how does it help JPS patients?
How does my genetic mutation affect my JPS treatment plan?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my (or my child’s) polyp burden currently low enough to be managed safely with endoscopy alone?
- 2.How do you manage the physical risks of frequent endoscopies, like bleeding or perforation, against the risk of cancer?
- 3.At what point would we shift from 'watchful waiting' via endoscopy to considering surgical options like a colectomy or gastrectomy?
- 4.Could sirolimus be an option to reduce polyp burden or manage protein loss before we consider major surgery?
- 5.What are the long-term nutritional consequences if a total gastrectomy or colectomy becomes necessary?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Juvenile polyposis syndrome: An overview.
Dal Buono A, Gaiani F, Poliani L, Laghi L
Best practice & research. Clinical gastroenterology 2022; (58-59()):101799 doi:10.1016/j.bpg.2022.101799.
PMID: 35988962 - 2
Juvenile polyposis syndrome: A case report.
Pérez-Castilla A, Peñailillo P, Oksenberg D
International journal of surgery case reports 2019; (59()):73-75 doi:10.1016/j.ijscr.2019.04.041.
PMID: 31108454 - 3
Management of Juvenile Polyposis Syndrome in Children and Adolescents: A Position Paper From the ESPGHAN Polyposis Working Group.
Cohen S, Hyer W, Mas E, et al.
Journal of pediatric gastroenterology and nutrition 2019; (68(3)):453-462 doi:10.1097/MPG.0000000000002246.
PMID: 30585890 - 4
SMAD4 variants and its genotype-phenotype correlations to juvenile polyposis syndrome.
Cao K, Plazzer JP, Macrae F
Hereditary cancer in clinical practice 2023; (21(1)):27 doi:10.1186/s13053-023-00267-z.
PMID: 38066625 - 5
Improvement in Protein-Losing Gastroenteropathy Due to Gastric Polyposis by Laparoscopic Total Gastrectomy: A Case Report.
Mizuno M, Saito T, Nakai S, et al.
Surgical case reports 2025; (11(1)) doi:10.70352/scrj.cr.25-0407.
PMID: 41122451 - 6
Massive juvenile polyposis of the stomach in a family with SMAD4 gene mutation.
de Leon MP, Pedroni M, Viel A, et al.
Familial cancer 2019; (18(2)):165-172 doi:10.1007/s10689-018-0100-8.
PMID: 30196345 - 7
Juvenile polyposis syndrome with gastric and duodenal polyposis presenting with refractory anemia and protein-leakage gastroenteropathy in a patient with SMAD4 mutation: a case report.
Nakamura K, Kubota K, Shimizu A, et al.
Surgical case reports 2024; (10(1)):11 doi:10.1186/s40792-023-01796-4.
PMID: 38191939 - 8
[A Case of Laparoscopic Total Gastrectomy for Juvenile Polyposis of Stomach with Synchronous Multiple Intramucosal Carcinomas].
Sakai J, Ono H, Otsubo K, et al.
Gan to kagaku ryoho. Cancer & chemotherapy 2022; (49(13)):1699-1701.
PMID: 36733181 - 9
Polygenic Infantile Juvenile Polyposis Syndrome Managed With Sirolimus and Endoscopic Polypectomy.
Bell LD, Bernat JA, Rahhal R
Gastroenterology research 2022; (15(1)):33-38 doi:10.14740/gr1480.
PMID: 35369680 - 10
Successful Treatment of Juvenile Polyposis of Infancy With Sirolimus.
Busoni VB, Orsi M, Lobos PA, et al.
Pediatrics 2019; (144(2)) doi:10.1542/peds.2018-2922.
PMID: 31366686 - 11
Sirolimus for the Treatment of Juvenile Polyposis in Childhood.
Martín-Masot R, Cardelo Autero N, Ortiz Pérez P, et al.
ACG case reports journal 2021; (8(8)):e00646 doi:10.14309/crj.0000000000000646.
PMID: 34476273 - 12
JP-HHT phenotype in Danish patients with SMAD4 mutations.
Jelsig AM, Tørring PM, Kjeldsen AD, et al.
Clinical genetics 2016; (90(1)):55-62 doi:10.1111/cge.12693.
PMID: 26572829
This page provides educational information on Juvenile Polyposis Syndrome treatments and management strategies. It does not replace professional medical advice. Always consult your gastroenterologist or care team about your specific treatment plan.
Get notified when new evidence is published on Juvenile polyposis syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.